Evolus Ownership | Who Owns Evolus?
Evolus Ownership Summary
Evolus is owned by 25.19% institutional investors, 11.95% insiders, and 62.86% retail investors. Nantahala capital management is the largest institutional shareholder, holding 8.87% of EOLS shares. BioPharma Credit Ord is the top mutual fund, with 8.78% of its assets in Evolus shares.
EOLS Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Evolus | 25.19% | 11.95% | 62.86% |
| Sector | Healthcare Stocks | 42.54% | 10.83% | 46.63% |
| Industry | Specialty & Generic Drug Manufacturers Stocks | 26.16% | 11.89% | 61.94% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Nantahala capital management | 5.73M | 8.87% | $35.16M |
| Tang capital management | 5.49M | 8.50% | $33.70M |
| Blackrock funding, inc. /de | 4.48M | 6.94% | $27.49M |
| Blackrock | 4.01M | 6.82% | $43.49M |
| Caligan partners lp | 4.14M | 6.41% | $25.41M |
| Vanguard group | 3.43M | 5.31% | $21.05M |
| Frazier life sciences management | 2.63M | 4.08% | $16.15M |
| Stonepine capital management | 1.54M | 2.38% | $9.43M |
| State street | 1.52M | 2.35% | $9.30M |
| Eversept partners, lp | 1.48M | 2.29% | $9.06M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Stonepine capital management | 1.54M | 7.67% | $9.43M |
| Allostery investments lp | 60.00K | 7.04% | $552.60K |
| Awh capital | 625.00K | 4.00% | $3.84M |
| Caligan partners lp | 4.14M | 3.33% | $25.41M |
| Altium capital management lp | 685.00K | 2.15% | $7.56M |
| Tang capital management | 5.49M | 1.30% | $33.70M |
| Cm management | 250.00K | 1.28% | $1.53B |
| Nantahala capital management | 5.73M | 1.22% | $35.16M |
| Soviero asset management, lp | 330.00K | 1.05% | $2.03M |
| Prospect capital advisors | 208.10K | 0.66% | $1.28M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Nantahala capital management | 5.73M | 1.22% | 1.53M |
| Caligan partners lp | 4.14M | 3.33% | 796.97K |
| Blackrock | 4.01M | 0.00% | 747.40K |
| Stonepine capital management | 1.54M | 7.67% | 619.89K |
| Tang capital management | 5.49M | 1.30% | 490.90K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Perceptive advisors | - | - | -2.47M |
| Frontier capital management | 270.51K | 0.01% | -1.39M |
| Tri locum partners lp | - | - | -1.24M |
| Soros fund management | - | - | -995.49K |
| Great point partners | - | - | -720.12K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Soviero asset management, lp | 330.00K | 1.05% | 330.00K | $2.03M |
| Caption management | 247.60K | 0.01% | 247.60K | $1.52M |
| Prospect capital advisors | 208.10K | 0.66% | 208.10K | $1.28M |
| American assets | 125.00K | 0.25% | 125.00K | $767.50K |
| Krensavage asset management | 100.00K | 0.26% | 100.00K | $614.00K |
Sold Out
| Holder | Change |
|---|---|
| National bank of canada /fi/ | -2.00 |
| True wealth design | -4.00 |
| Coldstream capital management | -12.00 |
| Lindbrook capital | -21.00 |
| Riggs asset managment | -39.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2025 | 71 | -60.77% | 16,258,044 | -72.12% | 25 | 0.31% | 35 | -61.96% | 19 | -62.75% |
| Jun 30, 2025 | 180 | -1.64% | 58,292,237 | 8.05% | 90 | 1.26% | 91 | 5.81% | 51 | -15.00% |
| Mar 31, 2025 | 183 | 9.58% | 54,281,287 | 4.55% | 85 | 1.26% | 86 | 4.88% | 61 | 29.79% |
| Dec 31, 2024 | 51 | -69.82% | 10,920,539 | -78.29% | 17 | 0.27% | 22 | -73.81% | 14 | -68.89% |
| Sep 30, 2024 | 168 | 3.07% | 50,297,352 | -2.04% | 79 | 1.19% | 84 | -14.29% | 45 | 18.42% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| BioPharma Credit Ord | 5.66M | 8.78% | -99.14K |
| Vanguard US Total Market Shares ETF | 1.68M | 2.65% | - |
| Vanguard Total Stock Mkt Idx Inv | 1.69M | 2.61% | -37.45K |
| iShares Russell 2000 ETF | 1.29M | 1.99% | - |
| Schroder US Smaller Companies Acc | 764.91K | 1.18% | - |
| Oberweis Micro-Cap Growth | 677.60K | 1.05% | - |
| Oberweis Micro-Cap | 677.60K | 1.05% | - |
| Xtrackers S&P 500 Swap ETF 1C | 578.12K | 0.92% | -153.31K |
| CREF Stock R1 | 572.75K | 0.90% | 245.42K |
| Vanguard Institutional Extnd Mkt Idx Tr | 544.78K | 0.84% | -237.22K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Aug 22, 2025 | Yamagishi-Dressler Tomoko | Chief Marketing Officer | Sell | $42.97K |
| Aug 15, 2025 | Stewart Brady | - | Buy | $204.49K |
| Jun 16, 2025 | MOATAZEDI DAVID | See Remarks | Sell | $164.05K |
| Jun 13, 2025 | MOATAZEDI DAVID | See Remarks | Sell | $1.12M |
| Jun 09, 2025 | White Albert G III | - | Buy | $189.00K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q2 | 1 | 5 |
| 2025 Q1 | - | 6 |
| 2024 Q4 | - | 3 |
| 2024 Q3 | - | 2 |
| 2024 Q2 | - | 10 |
EOLS Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools